doq.nl
Jun 26, 2025, 12:51
Heleen van Ommen Shares ISTH2025 Data on Edoxaban in Children with VTE
Heleen van Ommen, chair of the International Pediatric Thrombosis Network (IPTN), posted on X:
“ISTH2025 Efficacy and safety outcomes were comparable between edoxaban and standard of care in pediatric VTE patients according to Mihir Bhatt. Unfortunately, pre-defined non- inferiority margin was not met.”
Find similar posts on Hemostasis Today.
-
Sep 1, 2026, 09:16Nicolas Gendron: Real-World Data on Danaparoid in Patients with Suspected HIT
-
Sep 1, 2026, 08:24Cristina Chang: The Importance of The New ET Treatments
-
Sep 1, 2026, 07:22Abdul Mannan: ASH 2026 Guidelines – New Treatment Approach for Adult ITP
-
Sep 1, 2026, 07:20Alejandro González Veliz: Silent Atherosclerosis Starts Earlier Than We Think
-
Sep 1, 2026, 07:18Alan Nurden: A New Mechanism Behind Immune Thrombocytopenia
-
Sep 1, 2026, 07:18Susan Shea: New NHLBI Fellowship Supports Thrombinflammation Research
-
Sep 1, 2026, 07:12Sriraman Punniakoti: Pediatric ALL Therapy and Cerebrovascular Thrombosis
-
Sep 1, 2026, 07:04Piotr Czempik: ROTEM in Sepsis-Related Coagulopathy
-
Sep 1, 2026, 07:02Amin Omar Khlifat: Reading the Laboratory Clues to Differentiate Types of Anemia